GLP Training

Good Laboratory Practices are prerequisites for any organization conducting a non-clinical study. In order to assure the regulatory Authorities that the data submitted is reliable and consistent with the obtained results during the study, GLP training is important. HORN Pharmaceutical Consulting is offering active and creative workshops that foster a collaborative environment of interest to both practitioners and researchers. 

Our trainings can be offered as tailor-made webinars as well. Just contact us.

Our training programs are specifically designed to increase employee knowledge and broaden their experience in the area of GLP guidelines, specifications, and regulations.
After our training, all participants will have gained a fundamental understanding of the basis of the regulations, the necessity of rigorously implementing them, monitoring compliance and pro-active thinking in all scientific matters. This way the risk of non-compliance and delays in the approval process can be minimized.

In-house Training

The ability to have your specific concerns addressed and discussed is one of the most important factors in any educational program. All training courses will be adapted to your requirements and your target group and - if necessary - designed completely from scratch. After all, they have to be suited to your individual situation and provide your company with recognisable added value.

Services

Our GLP training covers but is not restricted to the following topics:
  • GLP-requirements (EU, US)
  • Product safety testing
  • Development and training of Standard Operating Procedures (SOPs)
  • Preparation and conduct of inspections (FDA, EMA, national supervisory Authorities)
  • Quality Control (QC) and Quality Assurance (QA) Systems
  • Analytical and laboratory validation and compliance programs
  • Inspection of facilities and processes
  • Performance of inspections of in-life phases
  • Audit of final reports

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

Get all events



News

  • 01.09.2022
    EU-GMP Annex 1 finally published
    More
  • 26.08.2022
    New Deadlines and Chances for Nitrosamines
    More
  • 25.08.2022
    Important Aspects to consider if you use Titanium Dioxide in your Drug Products
    More
Get all news